Details

Industries

Biotechnology,Health Care,Medical,Pharmaceutical

Founded date

Jan 1, 1998

Number Of Employee

101 - 250

Operating Status

Active

Esperion discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases. Esperion intends to commercialize a novel class of drugs that focuses on a new treatment approach called "HDL Therapy," which is based on the Company's understanding of high-density lipoprotein, or HDL, function.